Abstract
Transmission of enveloped viruses by blood products prepared from pooled plasma has fortunately become an extremely rare event due to the efficacy of the applied virus inactivation procedures. The inactivation procedures are, however, Much less effective against non-enveloped viruses such as human parvovirus B19 (B19) [for review, 1; 2]. Consequently, B19 infections in association with administration of plasma-derived products are still reported until now [3,4].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Azzi A, Morfini M, Mannucci PM (1999): The transfusion-associated transmission of parvovirus B19. Transfus Med Rev 13: 194–204
Schmidt I, BlÜmel J, Seitz H, Willkommen H, Löwer J (2001) Parvovirus B19 DNA in plasma pools and plasma derivatives. Vox Sang 81: 228–235
Hino M, Ishiko 0, Honda K-I, Yamane T, Ohta K, Takubo T, Tatsumi N (2000) Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br J Haematol 108: 194–195
Koenigbauer UF, Eastlund T, Day JW (2000) Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma. Transfusion 40: 1203–1206
Eis-HÜbinger AM, Sasowski U, Brackmann HH, Kaiser R, Matz B, Schneweis KE (1996) Parvovirus B19 DNA is frequently present in recombinant coagulation factor VIII products. Thromb Haemost 76: 1120
Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR (1986) Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 58: 921–936
Mori J, Beattie P, Melton DW, Cohen BJ, Clewley JP (1987) Structure and Mapping of the DNA of human parvovirus B19. J Gen Virol 68: 2797–2806
Hemauer A, von Poblotzki A, Gigler A, Cassinotti P, Siegl G, Wolf H, Modrow S (1996) Sequence variability among different parvovirus B19 isolates. J Gen Virol 77: 1781–1785
Johansen JN, Christensen LS, Zakrzewska K, Carlsen K, Hornsleth A, Azzi A (1998) Typing of European strains of parvovirus B19 by restriction endonuclease analyses and sequencing: identification of evolutionary lineages and evidence of recombination of Markers from different lineages. Virus Res 53: 215–223
Blundell MC, Beard C, Astell CR (1987) In vitro identification of a B19 parvovirus promoter. Virology 157: 534–538
Brown KE, Young NS, Alving BM, Barbosa LH (2001) Parvovirus B19: implications for transfusion Medicine. Summary of a workshop. Transfusion 41: 130–135
Cohen B (1995) Parvovirus B19: an expanding spectrum of disease. BMJ 311: 1549–1552
Cherry JD (1999) Parvovirus infections in children and adults. Adv Pediatr 46: 245–269
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Blümel, J. et al. (2003). Transmission of Parvovirus B19 by Heat-treated Coagulation Factor Concentrates. In: Scharrer, I., Schramm, W. (eds) 32nd Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18150-4_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-18150-4_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-43884-7
Online ISBN: 978-3-642-18150-4
eBook Packages: Springer Book Archive